the Web site devoted to the study of the glucagon-like peptides
This Web site is maintained by Dr. Daniel J. Drucker, Mount Sinai Hospital Samuel Lunenfeld Research Institute University of Toronto
Genetic predictions of the beta cell response to GLP-1 and the therapeutic responses to DPP-4 inhibitors GLP-1 action in type 2 diabetes
Cardioprotection and stem cell mobilization with DPP-4 inhibitors and G-CSF in mice DPP-4 and the Cardiovascular System
For updates to glucagon.com, Follow us on Twitter DanielJDrucker
